Human medicines European public assessment report (EPAR): Tasigna, nilotinib, Date of authorisation: 19/11/2007, Revision: 47, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 3 December 2024 - 14:20

Human medicines European public assessment report (EPAR): Tasigna, nilotinib, Date of authorisation: 19/11/2007, Revision: 47, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/tasigna

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters